ZI-XUAN Yang
发表
Knockdown by shRNA identifies SLC44A5 as a potential therapeutic target in hepatocellular carcinoma.
Ming-xia Li,
Ren Wang,
Qi-fa Ye,
2016,
Molecular medicine reports.
Q. Tan,
Yang Jin,
ZI-XUAN Yang,
2022,
Journal of Nanobiotechnology.
Q. Tan,
Jiangbin Chen,
Mengfei Guo,
2022,
Chemical Engineering Journal.
Jingjing Deng,
Q. Tan,
Jiangbin Chen,
2022,
Pharmaceutics.
Q. Tan,
Jiangbin Chen,
Mengfei Guo,
2022,
International journal of nanomedicine.